Skip to content
Stop using now Drug recall · FDA · Published September 9, 2021

Jacobus Ruzurgi 10mg Tablets Recall: Microbial Contamination Risk

Jacobus Pharmaceutical recalls Ruzurgi 10mg tablets due to microbial contamination. Products may contain excessive aerobic bacteria, yeast, or mold. Stop using affected lots immediately.

🇺🇸 FDA recall #D-0008-2022DrugJacobus Pharmaceutical ›
Take action

Contact the company

Recalling firmJacobus Pharmaceutical Company Inc.Industrial Research Laboratory Building, 31 Schalks Crossing Rd · Plainsboro, NJ 08536
✎ GovInfoNow plain-language explainer

Jacobus Pharmaceutical is recalling Ruzurgi (amifampridine) 10mg tablets because they were contaminated with harmful bacteria, yeast, and mold. This poses a risk of infection or illness if taken. Affected products must be stopped and discarded. Read more at govinfonow.com/recall/35860-jacobus-ruzurgi-10mg-tablets-recall-microbial-contamination-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/35860-jacobus-ruzurgi-10mg-tablets-recall-microbial-contamination-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0008-2022

Cite this page

“Jacobus Ruzurgi 10mg Tablets Recall: Microbial Contamination Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35860-jacobus-ruzurgi-10mg-tablets-recall-microbial-contamination-risk. Based on FDA recall #D-0008-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0008-2022%22&limit=1).

The FDA announced on Sept. 9, 2021, that Jacobus Pharmaceutical Company Inc. voluntarily recalled Ruzurgi (amifampridine) Tablets 10 mg due to microbial contamination risks. The Class I recall affects 2,324 bottles distributed in the USA and Canada.

How to tell if you have it

  • Brand: Jacobus Pharmaceutical
  • Product: Ruzurgi (amifampridine) Tablets 10 mg
  • Packaging: 100-count bottles
  • NDC: 49938-110-01
  • Lot codes: 18038, 18039 (Exp 03/2023); 18079 (Exp 05/2023)
  • Quantity: 2,324 bottles

The hazard

The FDA stated that the firm's testing found lots exceeded specifications for aerobic bacteria, yeast, and mold counts. This microbial contamination of non-sterile products poses a health risk to consumers.

Context

GovInfoNow records show other recent recalls include Fresenius Kabi Famotidine Injection (2025-11-06) and JB Chemicals Cetirizine Tablets (2026-06-24). Alembic also recalled Fesoterodine Tablets on 2025-12-16 due to impurity risks.

How to tell if you have this one

Check for Ruzurgi 10mg tablets in 100-count bottles, Rx only, manufactured by Jacobus Pharmaceutical. Look for lot numbers 18038, 18039 (expiring 03/2023) or 18079 (expiring 05/2023).

  • Brand
    Jacobus Pharmaceutical
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Immediately

    Discard all affected Ruzurgi tablets as they may cause infection or illness.

How this recall unfolded

Recall timeline

FDA terminated this recall 5 months after the firm started it.

1. Firm started the recall: Sep 9, 202112. Published in FDA’s Enforcement Report: Oct 6, 202123. FDA classified it Class I: Oct 8, 202134. FDA terminated the recall: Feb 18, 2022420212022
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class I
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0008-2022 (September 9, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0008-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA